Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
2002 1
2004 1
2005 3
2006 6
2007 11
2008 15
2009 10
2010 6
2011 5
2012 10
2013 8
2014 8
2015 10
2016 5
2017 5
2018 7
2019 8
2020 13
2021 10
2022 17
2023 12
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Results by year

Filters applied: . Clear all
Page 1
Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trials.
Kopelman ZA, Tian C, Tumas J, Phippen NT, Tarney CM, Hope ER, Winkler SS, Jokajtys S, Kucera CW, Chan JK, Richardson MT, Kapp DS, Hamilton CA, Leath CA 3rd, Jones NL, Rocconi RP, Farley JH, Secord AA, Cosgrove CM, Powell MA, Klopp A, Walker JL, Fleming GF, Bateman NW, Conrads TP, Maxwell GL, Darcy KM. Kopelman ZA, et al. Among authors: kapp ds. Gynecol Oncol. 2024 Apr 8;183:103-114. doi: 10.1016/j.ygyno.2024.03.026. Online ahead of print. Gynecol Oncol. 2024. PMID: 38593674
In Reply.
Bashi A, Somasegar S, Johnson C, Kapp DS, Chan JK. Bashi A, et al. Among authors: kapp ds. Obstet Gynecol. 2024 Apr 1;143(4):e131. doi: 10.1097/AOG.0000000000005544. Obstet Gynecol. 2024. PMID: 38513251 No abstract available.
Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer®-Accredited Facilities in the United States.
Sitler CA, Tian C, Hamilton CA, Richardson MT, Chan JK, Kapp DS, Leath CA 3rd, Casablanca Y, Washington C, Chappell NP, Klopp AH, Shriver CD, Tarney CM, Bateman NW, Conrads TP, Maxwell GL, Phippen NT, Darcy KM. Sitler CA, et al. Among authors: kapp ds. Cancers (Basel). 2024 Mar 6;16(5):1071. doi: 10.3390/cancers16051071. Cancers (Basel). 2024. PMID: 38473428 Free PMC article.
Survival disparities in non-Hispanic Black and White cervical cancer patients vary by histology and are largely explained by modifiable factors.
Kucera CW, Chappell NP, Tian C, Richardson MT, Tarney CM, Hamilton CA, Chan JK, Kapp DS, Leath CA 3rd, Casablanca Y, Rojas C, Sitler CA, Wenzel L, Klopp A, Jones NL, Rocconi RP, Farley JH, O'Connor TD, Shriver CD, Bateman NW, Conrads TP, Phippen NT, Maxwell GL, Darcy KM. Kucera CW, et al. Among authors: kapp ds. Gynecol Oncol. 2024 Feb 9;184:224-235. doi: 10.1016/j.ygyno.2024.02.005. Online ahead of print. Gynecol Oncol. 2024. PMID: 38340648
Racial, ethnic and country of origin disparities in aggressive endometrial cancer histologic subtypes.
Winkler SS, Tian C, Casablanca Y, Bateman NW, Jokajtys S, Kucera CW, Tarney CM, Chan JK, Richardson MT, Kapp DS, Liao CI, Hamilton CA, Leath CA 3rd, Reddy M, Cote ML, O'Connor TD, Jones NL, Rocconi RP, Powell MA, Farley J, Shriver CD, Conrads TP, Phippen NT, Maxwell GL, Darcy KM. Winkler SS, et al. Among authors: kapp ds. Gynecol Oncol. 2024 Jan 25;184:31-42. doi: 10.1016/j.ygyno.2024.01.009. Online ahead of print. Gynecol Oncol. 2024. PMID: 38277919
Preoperative and pre-chemotherapy CA-125 levels in high-risk early-stage ovarian cancer - An NRG/GOG study.
Chan JK, Tian C, Kesterson JP, Lin KY, Darcy K, Richardson MT, Kapp DS, Monk BJ, McNally L, Landrum L, Copeland L, Walker JL, Wenham RM, Phippen N, Spirtos NM, Tewari K, Shahin M, Berry L, Bell JG. Chan JK, et al. Among authors: kapp ds. Gynecol Oncol. 2024 Feb;181:54-59. doi: 10.1016/j.ygyno.2023.12.009. Epub 2023 Dec 21. Gynecol Oncol. 2024. PMID: 38134754 Clinical Trial.
Underrepresentation of racial and ethnic minority groups in gynecologic oncology: An analysis of over 250 trials.
Richardson MT, Barry D, Steinberg JR, Thirunavu V, Strom DE, Holder K, Zhang N, Turner BE, Magnani CJ, Weeks BT, Young AMP, Lu CF, Wolgemuth TR, Laasiri N, Squires NA, Anderson JN, Karlan BY, Chan JK, Kapp DS, Roque DR, Salani R. Richardson MT, et al. Among authors: kapp ds. Gynecol Oncol. 2024 Feb;181:1-7. doi: 10.1016/j.ygyno.2023.12.001. Epub 2023 Dec 13. Gynecol Oncol. 2024. PMID: 38096673
154 results